Anders Carlson, MD
Endocrinology, Diabetes & Metabolism · St Louis Park, MNNPI 1720254725
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 39.8% of the total. Among endocrinology, diabetes & metabolism clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $920.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$65K
- Abbott$40K
- Novo Nordisk$19K
- Insulet Corporation$15K
- Mannkind Corporation$10K
- Eli Lilly$4K
- plus $9K from 9 others
Across 491 payments — averaging $11,054 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$3.1M
- Insulet Corporation$1.5M
- Eli Lilly$267K
- Sequel Med Tech, LLC$196K
- Novo Nordisk AS$168K
- Tandem Diabetes Care, Inc.$104K
- plus $87K from 3 others
What the payments were for
- Consulting fees$53,76133%
- Speaking & faculty fees$87,07853%
- Travel & lodging$17,67811%
- Food & beverage$4,3363%
- Gifts$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 76 | $64,888 |
| Abbott | 8 | $40,124 |
| Novo Nordisk | 12 | $19,298 |
| Insulet Corporation | 19 | $14,862 |
| Mannkind Corporation | 18 | $10,089 |
| Eli Lilly | 23 | $4,460 |
| Zealand Pharma A/s | 2 | $3,560 |
| Lilly USA, LLC | 1 | $1,575 |
| Ascensia Diabetes Care US Inc. | 1 | $1,500 |
| Novo Nordisk AS | 7 | $866 |
| Sanofi-aventis U.S. LLC | 3 | $720 |
| Companion Medical, Inc. | 1 | $500 |
| Dexcom, Inc. | 3 | $280 |
| Polarityte, Inc. | 2 | $122 |
| Senseonics, Incorporated | 1 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InPen$17,500
- Omnipod$14,457
- Minimed 670G System$10,326
- AFREZZA$9,583
- Tresiba$8,160
- Minimed 770G System$4,200
- MINIMED 780G$1,492
- TOUJEO$720
- Saxenda$716
- DEXCOM G6 TRANSMITTER$225
- SkinTE$102
How this compares
$162,896 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.
See all endocrinology, diabetes & metabolism providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in St Louis Park
- Richard BergenstalSt Louis Park$595K
- Laura LafaveSt Louis Park$1K
- Mary MokSt Louis Park$422
- Haleigh JamesSt Louis Park$263
- Farha KhanCoon Rapids$349K
- Mark HolmSaint Cloud$318K
- Marjorie Ann MalbasRochester$222K
- Maria CaramoriMinneapolis$147K
- Irina BancosRochester$114K
- Sidney JonesChaska$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.